预测代谢功能障碍相关型肝炎肝硬化患者的等待列表轨迹:一个神经网络竞争风险分析
Gopika Punchhi1,2, Yingji Sun2, Eunice Tan2,3,4
1Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Journal of medical Internet research
|January 29, 2026
概括
深度学习模型可以预测患有代谢功能障碍相关的脂肪肝肝硬化症患者的肝移植等候名单结果. 这种方法可以更好地预测移植和死亡风险,帮助临床决策.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植医学 移植医学
- 医疗保健中的人工智能
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 肝硬化是肝移植 (LT) 的主要驱动因素.
- 目前的肝脏分配系统 (基于MELD) 在预测MASH患者等待名单死亡率方面存在局限性.
- 现有的模型无法充分考虑等待名单上的死亡和LT的竞争风险.
研究的目的:
- 开发和验证一个深度学习模型,用于预测MASH肝硬化患者的等候名单轨迹.
- 将深度学习的预测性能与竞争风险的传统模型进行比较.
- 为了确定影响肝移植等候名单患者结果的关键因素.
主要方法:
- 一个深度学习竞争风险模型 (DeepHit) 是使用来自17551名MASH肝硬化患者的数据开发的.
- 模型性能使用一致性指数,布里尔得分和一种新的竞争事件连贯性 (CEC) 评分来评估.
- 进行了外部验证,特征重要性分析确定了关键预测变量.
主要成果:
- DeepHit在多个时间点 (1-12个月) 预测竞争风险方面表现出优异的CEC分数.
- 随机生存森林 (RSF) 显示死亡和移植的一致性指数较高,除了3个月死亡.
- 确定MELD得分,功能状态,年龄和血型是等候名单结果的重要预测因素.
结论:
- 深度学习竞争性风险分析为预测MASH患者的死亡和移植风险提供了强大的方法.
- 这种方法可以通过突出关键的预后因素来加强临床决策.
- 这项研究强调了人工智能在优化肝移植等候名单管理方面的潜力.
相关概念视频
Orthogonal Trajectories
49
Orthogonal trajectories describe the geometric relationship between two families of curves that intersect each other at right angles. One illustrative case involves a family of parabolas that open sideways along the x-axis. These curves share a common shape but differ by a scaling parameter, resulting in a set of curves that all pass through the origin and widen at different rates.Determining Orthogonal TrajectoriesTo identify the orthogonal trajectories for these parabolas, the first step...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism
223
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
215
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
181
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
181
What is Metabolism?
131.7K
Overview
131.7K
Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K


